G H Tofler - JoVE Visualize

Showing results (61-70 of 75) with videos related to

Pageof 8

Sort By:

Circulation|October 4, 2000

Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring PopulationJ J Stec, H Silbershatz, G H Tofler, et al.

JAMA|January 14, 2000

Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring StudyJ B Meigs, M A Mittleman, D M Nathan, et al.

Journal of the American College of Cardiology|November 20, 1998

Effects of therapy with nifedipine GITS or atenolol on mental stress-induced ischemic left ventricular dysfunctionT C Andrews, J D Parker, S Jacobs, et al.

Circulation|March 1, 1989

Suppression of silent ischemia by metoprolol without alteration of morning increase of platelet aggregability in patients with stable coronary artery diseaseS N Willich, S Pohjola-Sintonen, S J Bhatia, et al.

Circulation|July 12, 2001

Platelet glycoprotein IIIa Pl(a) polymorphism, fibrinogen, and platelet aggregability: The Framingham Heart StudyD Feng, K Lindpaintner, M G Larson, et al.

Journal of Dental Research|December 24, 2005

Full-mouth tooth extraction lowers systemic inflammatory and thrombotic markers of cardiovascular riskB A Taylor, G H Tofler, H M R Carey, et al.

The American Journal of Cardiology|October 1, 1987

Prognosis after cardiac arrest due to ventricular tachycardia or ventricular fibrillation associated with acute myocardial infarction (the MILIS Study). Multicenter Investigation of the Limitation of Infarct SizeG H Tofler, P H Stone, J E Muller, et al.

Journal of the American College of Cardiology|March 1, 1987

Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black womenG H Tofler, P H Stone, J E Muller, et al.

The American Journal of Cardiology|February 15, 1997

Hemorrhagic events during therapy with recombinant tissue plasminogen activator, heparin, and aspirin for unstable angina (Thrombolysis in Myocardial Ischemia, phase IIIB trial)E G Bovill, R P Tracy, G L Knatterud, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2000

Factor VII gene polymorphism, factor VII levels, and prevalent cardiovascular disease: the Framingham Heart StudyD Feng, G H Tofler, M G Larson, et al.

Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:

Pageof 8

Circulation|October 4, 2000

Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring PopulationJ J Stec, H Silbershatz, G H Tofler, et al.

JAMA|January 14, 2000

Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring StudyJ B Meigs, M A Mittleman, D M Nathan, et al.

Journal of the American College of Cardiology|November 20, 1998

Effects of therapy with nifedipine GITS or atenolol on mental stress-induced ischemic left ventricular dysfunctionT C Andrews, J D Parker, S Jacobs, et al.

Circulation|March 1, 1989

Suppression of silent ischemia by metoprolol without alteration of morning increase of platelet aggregability in patients with stable coronary artery diseaseS N Willich, S Pohjola-Sintonen, S J Bhatia, et al.

Circulation|July 12, 2001

Platelet glycoprotein IIIa Pl(a) polymorphism, fibrinogen, and platelet aggregability: The Framingham Heart StudyD Feng, K Lindpaintner, M G Larson, et al.

Journal of Dental Research|December 24, 2005

Full-mouth tooth extraction lowers systemic inflammatory and thrombotic markers of cardiovascular riskB A Taylor, G H Tofler, H M R Carey, et al.

The American Journal of Cardiology|October 1, 1987

Prognosis after cardiac arrest due to ventricular tachycardia or ventricular fibrillation associated with acute myocardial infarction (the MILIS Study). Multicenter Investigation of the Limitation of Infarct SizeG H Tofler, P H Stone, J E Muller, et al.

Journal of the American College of Cardiology|March 1, 1987

Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black womenG H Tofler, P H Stone, J E Muller, et al.

The American Journal of Cardiology|February 15, 1997

Hemorrhagic events during therapy with recombinant tissue plasminogen activator, heparin, and aspirin for unstable angina (Thrombolysis in Myocardial Ischemia, phase IIIB trial)E G Bovill, R P Tracy, G L Knatterud, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2000

Factor VII gene polymorphism, factor VII levels, and prevalent cardiovascular disease: the Framingham Heart StudyD Feng, G H Tofler, M G Larson, et al.

Pageof 8